These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Outcome of childhood lupus nephritis in Saudi children. Al-Mayouf SM; AlAmeer A; Alfattani A; Alsonbul A Saudi J Kidney Dis Transpl; 2017; 28(5):1015-1020. PubMed ID: 28937057 [TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of nephritis response and renal outcome in a cohort of 928 Egyptian lupus nephritis patients: a university hospital experience. Momtaz M; Fayed A; Wadie M; Gamal SM; Ghoniem SA; Sobhy N; Kamal Elden NM; Hamza WM Lupus; 2017 Dec; 26(14):1564-1570. PubMed ID: 28625079 [TBL] [Abstract][Full Text] [Related]
10. A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis. F L; Y T; X P; L W; H W; Z S; H Z; Z H; Lupus; 2008 Jul; 17(7):622-9. PubMed ID: 18625634 [TBL] [Abstract][Full Text] [Related]
14. Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression. Mak A; Cheak AA; Tan JY; Su HC; Ho RC; Lau CS Rheumatology (Oxford); 2009 Aug; 48(8):944-52. PubMed ID: 19494179 [TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil for remission induction in severe lupus nephritis. Cross J; Dwomoa A; Andrews P; Burns A; Gordon C; Main J; Mathieson P; O'Donoghue D; Jayne D; Nephron Clin Pract; 2005; 100(3):c92-100. PubMed ID: 15824513 [TBL] [Abstract][Full Text] [Related]
16. 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis. Fanouriakis A; Kostopoulou M; Cheema K; Anders HJ; Aringer M; Bajema I; Boletis J; Frangou E; Houssiau FA; Hollis J; Karras A; Marchiori F; Marks SD; Moroni G; Mosca M; Parodis I; Praga M; Schneider M; Smolen JS; Tesar V; Trachana M; van Vollenhoven RF; Voskuyl AE; Teng YKO; van Leew B; Bertsias G; Jayne D; Boumpas DT Ann Rheum Dis; 2020 Jun; 79(6):713-723. PubMed ID: 32220834 [TBL] [Abstract][Full Text] [Related]
18. [Mycophenolate mofetil for the treatment of lupus nephritis. The case of lupus nephritis--class IV according to WHO--treated with mycophenolate mofetil]. Suszek D; Wielosz E; Majdan M Ann Acad Med Stetin; 2010; 56 Suppl 1():91-4. PubMed ID: 21365951 [TBL] [Abstract][Full Text] [Related]
19. Dutch guidelines for diagnosis and therapy of proliferative lupus nephritis. van Tellingen A; Voskuyl AE; Vervloet MG; Bijl M; de Sévaux RG; Berger SP; Derksen RH; Berden JH; Neth J Med; 2012 May; 70(4):199-207. PubMed ID: 22641632 [TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis. Sahin GM; Sahin S; Kiziltas S; Masatlioglu S; Oguz F; Ergin H Ren Fail; 2008; 30(9):865-9. PubMed ID: 18925525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]